Preparation of magnetic mesoporous silica nanoparticles as a multifunctional platform for potential drug delivery and hyperthermia

We report the preparation of magnetic mesoporous silica (MMS) nanoparticles with the potential multifunctionality of drug delivery and magnetic hyperthermia. Carbon-encapsulated magnetic colloidal nanoparticles (MCN@C) were used to coat mesoporous silica shells for the formation of the core-shell structured MMS nanoparticles (MCN@C/mSiO(2)), and the rattle-type structured MMS nanoparticles (MCN/mSiO(2)) were obtained after the removal of the carbon layers from MCN@C/mSiO(2) nanoparticles. The morphology, structure, magnetic hyperthermia ability, drug release behavior, in vitro cytotoxicity and cellular uptake of MMS nanoparticles were investigated. The results revealed that the MCN@C/mSiO(2) and MCN/mSiO(2) nanoparticles had spherical morphology and average particle sizes of 390 and 320 nm, respectively. The MCN@C/mSiO(2) nanoparticles exhibited higher magnetic hyperthermia ability compared to the MCN/mSiO(2) nanoparticles, but the MCN/mSiO(2) nanoparticles had higher drug loading capacity. Both MCN@C/mSiO(2) and MCN/mSiO(2) nanoparticles had similar drug release behavior with pH-controlled release and temperature-accelerated release. Furthermore, the MCN@C/mSiO(2) and MCN/mSiO(2) nanoparticles showed low cytotoxicity and could be internalized into HeLa cells. Therefore, the MCN@C/mSiO(2) and MCN/mSiO(2) nanoparticles would be promising for the combination of drug delivery and magnetic hyperthermia treatment in cancer therapy.